Looks Health

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE204N01013
  • NSEID:
  • BSEID: 534422
INR
8.65
0.09 (1.05%)
BSENSE

Jul 10, 04:01 PM

BSE+NSE Vol: 7.52 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

7.52 k (-57.44%) Volume

Shareholding (Mar 2026)

FII

16.99%

Held by 2 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

0.00%

Why is Looks Health Services Ltd falling/rising?

10-Jul-2026

As of 09-Jul, Looks Health Services Ltd's stock price is slightly rising at 8.56, but it has declined by 3.71% over the past week and 5.41% in the last month. Year-to-date, it has gained 54.51%, significantly outperforming the Sensex, although decreased investor participation may indicate waning interest.

As of 09-Jul, Looks Health Services Ltd's stock price is rising slightly, with a current price of 8.56, reflecting a change of 0.01 (0.12%) upward. Despite this minor increase, the stock has shown a negative performance over the past week, declining by 3.71%, while the benchmark Sensex has only decreased by 0.98% during the same period. <BR><BR>In the last month, the stock has fallen by 5.41%, contrasting sharply with the Sensex, which has risen by 3.82%. However, the year-to-date performance is notably strong, with a gain of 54.51%, while the Sensex has dropped by 9.95%. Over the past year, the stock has increased by 73.63%, significantly outperforming the Sensex, which has declined by 8.13%. <BR><BR>The stock's performance today is reported to be in line with its sector, but it is important to note that investor participation has decreased, with delivery volume falling by 86.72% compared to the 5-day average. This decline in participation could indicate waning interest among investors, despite the stock's current price increase. Additionally, while the stock is trading above its 50-day, 100-day, and 200-day moving averages, it is below its 5-day and 20-day moving averages, suggesting mixed signals regarding its short-term momentum. <BR><BR>Overall, while the stock is experiencing a slight rise today, the broader context shows a recent trend of declining performance over shorter periods, which may be contributing to cautious investor sentiment.

View full answer

Which are the latest news on Looks Health?

10-Jul-2026

How big is Looks Health?

11-Jun-2026

As of 10th June, Looks Health Services Ltd has a market capitalization of 10.00 Cr and reported net sales of 0.38 Cr and net profit of 0.03 Cr over the latest four quarters. Shareholder's funds are 14.80 Cr, with total assets of 14.85 Cr as of March 2024.

As of 10th June, <BR><BR>Market Cap: Looks Health Services Ltd has a market capitalization of 10.00 Cr, categorized as a Micro Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 0.38 Cr, while the sum of Net Profit for the same period is 0.03 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2024, with Shareholder's Funds amounting to 14.80 Cr and Total Assets totaling 14.85 Cr.

View full answer

Who are in the management team of Looks Health?

11-Jun-2026

The management team of Looks Health includes Pritesh Champalal Doshi (Chairperson & Managing Director), Kanchan Kaku (Company Secretary & Compliance Officer), Sejal Jain (Independent Director), and Devendra Sanghvi (Independent Director).

The management team of Looks Health includes the following individuals:<BR><BR>1. **Pritesh Champalal Doshi** - Chairperson & Managing Director<BR>2. **Kanchan Kaku** - Company Secretary & Compliance Officer<BR>3. **Sejal Jain** - Independent Director<BR>4. **Devendra Sanghvi** - Independent Director<BR><BR>If you need more details about their roles or the company, feel free to ask!

View full answer

Who are the peers of the Looks Health?

11-Jun-2026

Peers of Looks Health include Adeshwar Meditex, Transgene Biotek, Family Care, Vanta Bioscience, Clinitech Lab, Dr Lalchand. Lab, Dhanvantri Jeev., Ashram Online, and Gian Lifecare. Looks Health has the highest 1-year return at 96.39%, significantly outperforming its peers.

Peers: The peers of Looks Health are Adeshwar Meditex, Transgene Biotek, Family Care, Vanta Bioscience, Clinitech Lab, Dr Lalchand. Lab, Dhanvantri Jeev., Ashram Online, Gian Lifecare.<BR><BR>Quality Snapshot: Below Average management risk is observed at Adeshwar Meditex, Vanta Bioscience, Clinitech Lab, Dr Lalchand. Lab, Dhanvantri Jeev., Gian Lifecare, and the rest. Average management risk is found at Family Care, while Transgene Biotek and Ashram Online do not qualify. Growth is rated as Good at Family Care, Average at Family Care, and Below Average at Adeshwar Meditex, Vanta Bioscience, Clinitech Lab, Dr Lalchand. Lab, Dhanvantri Jeev., Gian Lifecare, and the rest. Capital Structure is Excellent at Family Care, Good at Clinitech Lab, Dr Lalchand. Lab, Dhanvantri Jeev., Gian Lifecare, and Average at Adeshwar Meditex, Vanta Bioscience, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Looks Health at 96.39%, while the lowest is Family Care at -29.31%. Looks Health's 1-year return significantly outperforms all peers. Additionally, the six-month return is negative for Adeshwar Meditex, Vanta Bioscience, Dr Lalchand. Lab, Dhanvantri Jeev., Ashram Online, and Gian Lifecare.

View full answer

What does Looks Health do?

10-Jun-2026

Looks Health Services Ltd provides surgical and non-surgical cosmetic and aesthetic treatments. As of March 2026, the company reported net sales and profit of 0 Cr, with a market cap of INR 10 Cr.

Overview:<BR>Looks Health Services Ltd operates in the healthcare services industry, specifically providing both surgical and non-surgical cosmetic and aesthetic treatments.<BR><BR>History:<BR>The company was incorporated in October 2011 under the name 'Monarch Health Services Limited' and changed its name to 'Looks Health Services Limited' in March 2013. The latest quarterly results reported net sales and net profit of 0 Cr for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 0 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 0 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 10 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 45.00 <BR>Industry P/E: 60 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.08 <BR>Return on Equity: 1.48% <BR>Price to Book: 0.64 <BR><BR>Contact Details:<BR>Address: A/203 Green Villa above pizza, Lokhandwala Complex Andheri(W) Mumbai Maharashtra : 400053 <BR>Tel: 91-22-42952616 <BR>Email: cs@looksclinic.com <BR>Website: http://www.looksclinic.in

View full answer

When is the next results date for Looks Health Services Ltd?

12-May-2026

The next results date for Looks Health Services Ltd is 20 May 2026.

The next results date for Looks Health Services Ltd is scheduled for 20 May 2026.

View full answer

Who are the top shareholders of the Looks Health?

17-Jul-2025

The top shareholders of Looks Health are Maxgainz Finserve Private Limited with 13.09%, Wave Capital Ltd and a foreign institutional investor each holding 6.93%, while individual investors collectively own 75.82% of the shares. There are no pledged promoter holdings or mutual fund investments in the company.

The top shareholders of Looks Health include Maxgainz Finserve Private Limited, which holds the highest promoter stake at 13.09%. Additionally, Wave Capital Ltd is the highest public shareholder, owning 6.93%. The company also has one foreign institutional investor (FII) holding 6.93%. Individual investors collectively hold a significant portion, accounting for 75.82% of the shares. There are no pledged promoter holdings, and no mutual funds are currently invested in the company.

View full answer

Is Looks Health overvalued or undervalued?

09-Jun-2025

As of April 25, 2023, Looks Health is considered overvalued and risky, with a low PE ratio of 5.25 and negative EV to EBITDA, despite a recent one-month stock return of 8.89%, which contrasts with its troubling one-year return of -10.09%.

As of 25 April 2023, Looks Health's valuation grade has moved from does not qualify to risky, indicating a significant shift in its perceived financial health. The company is currently assessed as overvalued, with a PE ratio of 5.25, an EV to EBITDA of -4.94, and a PEG ratio of 0.02, all of which suggest that the stock may not be a sound investment relative to its peers.<BR><BR>In comparison to its industry, Looks Health's PE ratio is starkly lower than that of Max Healthcare at 100.29 and Apollo Hospitals at 69.03, both of which are considered very expensive. Furthermore, the company's negative EV to EBITDA ratio highlights underlying operational challenges. Despite a recent one-month stock return of 8.89%, which outperformed the Sensex's 3.87%, the longer-term performance shows a concerning trend, with a one-year return of -10.09% compared to the Sensex's 7.61%. This reinforces the view that Looks Health is currently overvalued in the market.

View full answer

What is the technical trend for Looks Health?

09-Jun-2025

As of June 6, 2025, Looks Health's trend is neutral with mixed indicators, showing a shift from mildly bearish to sideways, as weekly signals are mildly bullish while daily and monthly indicators suggest weakness and uncertainty.

As of 6 June 2025, the technical trend for Looks Health has changed from mildly bearish to sideways. The current stance is neutral, with mixed indicators influencing the outlook. The weekly MACD and Dow Theory are both mildly bullish, suggesting some positive momentum, while the daily moving averages indicate a mildly bearish trend. The Bollinger Bands show a bullish signal on the weekly chart but are mildly bearish on the monthly. The KST is mildly bullish weekly but bearish monthly, and the RSI shows no signal in both time frames. Overall, the strength of the trend is weak, reflecting uncertainty in the market.

View full answer

How has been the historical performance of the Looks Health?

07-Jun-2025

Looks Health has experienced a significant decline in net sales from Rs 1.14 crore in March 2019 to Rs 0.39 crore in March 2025, with negative operating profit margins for most years, though recent signs of recovery in profits are noted. Total assets have slightly decreased, and cash flow activities have remained stagnant.

Answer:<BR>The historical performance of Looks Health shows a fluctuating trend in its financial metrics over the years, with notable changes in net sales, profits, and expenses.<BR><BR>Breakdown:<BR>Looks Health's net sales have seen a significant decline from Rs 1.14 crore in March 2019 to Rs 0.39 crore in March 2025, with several years recording negligible sales. The total operating income followed a similar pattern, peaking at Rs 0.78 crore in March 2020 before dropping to Rs 0.39 crore in March 2025. The company has consistently reported no raw material costs, but employee costs have increased from Rs 0.64 crore in March 2019 to Rs 0.34 crore in March 2025. Operating profit margins have been negative for most years, with a notable -58.97% in March 2025, while the gross profit margin improved to 41.03% in the same year. Profit before tax showed a recovery to Rs 0.03 crore in March 2025 after several years of losses, and profit after tax also turned positive at Rs 0.02 crore. The company's total liabilities have remained relatively stable, with total assets slightly declining from Rs 15.36 crore in March 2019 to Rs 14.85 crore in March 2024. Cash flow activities have been stagnant, with no cash inflow or outflow reported across the years. Overall, Looks Health has faced challenges in maintaining sales and profitability, but recent signs of recovery in profits may indicate a potential turnaround.

View full answer

What is the bonus history of the Looks Health?

06-Jun-2025

Looks Health issued a 3:4 bonus on October 29, 2015, with a record date of October 30, 2015, allowing eligible shareholders to receive additional shares based on that ratio.

Looks Health has a history of issuing bonuses, with the most recent being a 3:4 bonus issue announced on October 29, 2015. The record date for this bonus was October 30, 2015. This means that shareholders on record as of that date would have received additional shares based on the specified ratio. If you have any more questions about Looks Health or its financial activities, feel free to ask!

View full answer

Has Looks Health declared dividend?

06-Jun-2025

No Dividend History Available

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 9 Cr (Micro Cap)

stock-summary
P/E

41.00

stock-summary
Industry P/E

63

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.08

stock-summary
Return on Equity

1.48%

stock-summary
Price to Book

0.61

Revenue and Profits:
Net Sales:
0 Cr
(Quarterly Results - Mar 2026)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
44.89%
0%
44.89%
6 Months
62.9%
0%
62.9%
1 Year
57.27%
0%
57.27%
2 Years
35.37%
0%
35.37%
3 Years
78.35%
0%
78.35%
4 Years
-4.1%
0%
-4.1%
5 Years
-27.92%
0%
-27.92%

Looks Health for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Closure of Trading Window

25-Jun-2026 | Source : BSE

Intimation of Closure of Trading Window for the quarter ended on 30th June2026

Announcement under Regulation 30 (LODR)-Newspaper Publication

21-May-2026 | Source : BSE

Kindly find the enclosed newspaper publication for the financial result for the quarter and year ended on 31st March2026.

Announcement under Regulation 30 (LODR)-Change in Management

20-May-2026 | Source : BSE

Please find the disclosure for appointment of Internal Auditor.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Looks Health Services Ltd has announced 3:4 bonus issue, ex-date: 29 Oct 15

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
9.02%
EBIT Growth (5y)
14.41%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.08
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
16.99%
ROCE (avg)
-3.11%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
41
Industry P/E
63
Price to Book Value
0.61
EV to EBIT
7.88
EV to EBITDA
7.88
EV to Capital Employed
0.58
EV to Sales
7.88
PEG Ratio
0.18
Dividend Yield
NA
ROCE (Latest)
1.39%
ROE (Latest)
1.48%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 2 FIIs (16.99%)

Promoter with highest holding

None

Highest Public shareholder

Wave Capital Ltd (9.98%)

Individual Investors Holdings

73.5%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -69.23% vs 0.00% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -94.74% vs 2,000.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.12",
          "val2": "0.39",
          "chgp": "-69.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.04",
          "val2": "0.19",
          "chgp": "-78.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.01",
          "val2": "0.19",
          "chgp": "-94.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "33.33%",
          "val2": "48.72%",
          "chgp": "-15.39%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 0.00% vs -100.00% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 0.00% vs -100.00% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.30",
          "val2": "-0.16",
          "chgp": "-87.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.13",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 0.00% vs -100.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -1,500.00% vs -150.00% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.41",
          "val2": "-0.25",
          "chgp": "-64.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.16",
          "val2": "-0.01",
          "chgp": "-1,500.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 0.00% vs 200.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.39",
          "val2": "0.39",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.17",
          "val2": "-0.23",
          "chgp": "173.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.02",
          "val2": "0.02",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "43.59%",
          "val2": "-58.97%",
          "chgp": "102.56%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
0.12
0.39
-69.23%
Operating Profit (PBDIT) excl Other Income
0.04
0.19
-78.95%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.01
0.19
-94.74%
Operating Profit Margin (Excl OI)
33.33%
48.72%
-15.39%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is -69.23% vs 0.00% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Mar 2026 is -94.74% vs 2,000.00% in Mar 2025

Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary

Sep'24
Sep'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.30
-0.16
-87.50%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.13
0.00
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 0.00% vs -100.00% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 0.00% vs -100.00% in Sep 2023

Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.41
-0.25
-64.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.16
-0.01
-1,500.00%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 0.00% vs -100.00% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -1,500.00% vs -150.00% in Dec 2023

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
0.39
0.39
Operating Profit (PBDIT) excl Other Income
0.17
-0.23
173.91%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.02
0.02
Operating Profit Margin (Excl OI)
43.59%
-58.97%
102.56%
Values in Rs Cr.
Net Sales

YoY Growth in year ended Mar 2026 is 0.00% vs 0.00% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 0.00% vs 200.00% in Mar 2025

stock-summaryCompany CV
About Looks Health Services Ltd stock-summary
stock-summary
Looks Health Services Ltd
Micro Cap
Healthcare Services
Looks Health Services Limited, which formerly incorporated in the name of 'Monarch Health Services Limited' in October, 2011 was changed to the present name 'Looks Health Services Limited' in March, 2013. Looks Cosmetic Clinic is India's first ever clinic with the pioneering concept of a single clinic equipped for both surgical and non-surgical cosmetic and aesthetic treatments.
Company Coordinates stock-summary
Company Details
A/203 Green Villa above pizza, Lokhandwala Complex Andheri(W) Mumbai Maharashtra : 400053
stock-summary
Tel: 91-22-42952616
stock-summary
cs@looksclinic.com
Registrar Details
Skyline Financial Services Pvt Ltd , D-153/A, 1st Floor, Okhla Industrial Area, Phase - I, New Delhi